These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7654109)
1. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Materson BJ; Reda DJ; Preston RA; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R Arch Intern Med; 1995 Sep; 155(16):1757-62. PubMed ID: 7654109 [TBL] [Abstract][Full Text] [Related]
2. Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents. Materson BJ; Reda DJ; Cushman WC; Henderson WG J Hum Hypertens; 1995 Oct; 9(10):791-6. PubMed ID: 8576893 [TBL] [Abstract][Full Text] [Related]
3. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Preston RA; Materson BJ; Reda DJ; Hamburger RJ; Williams DW; Smith MH Clin Nephrol; 1997 May; 47(5):310-5. PubMed ID: 9181278 [TBL] [Abstract][Full Text] [Related]
4. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Materson BJ; Reda DJ; Cushman WC; Massie BM; Freis ED; Kochar MS; Hamburger RJ; Fye C; Lakshman R; Gottdiener J N Engl J Med; 1993 Apr; 328(13):914-21. PubMed ID: 8446138 [TBL] [Abstract][Full Text] [Related]
5. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial. Cushman WC; Materson BJ; Williams DW; Reda DJ Hypertension; 2001 Oct; 38(4):953-7. PubMed ID: 11641316 [TBL] [Abstract][Full Text] [Related]
6. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Gottdiener JS; Reda DJ; Massie BM; Materson BJ; Williams DW; Anderson RJ Circulation; 1997 Apr; 95(8):2007-14. PubMed ID: 9133508 [TBL] [Abstract][Full Text] [Related]
7. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Preston RA; Materson BJ; Reda DJ; Williams DW; Hamburger RJ; Cushman WC; Anderson RJ JAMA; 1998 Oct; 280(13):1168-72. PubMed ID: 9777817 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
9. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group. Joglekar SJ; Jaguste V; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
11. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
12. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy]. Metelitsa VI; Filatova NP Ter Arkh; 1991; 63(8):30-4. PubMed ID: 1792612 [TBL] [Abstract][Full Text] [Related]
13. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group. Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385 [TBL] [Abstract][Full Text] [Related]
14. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665 [TBL] [Abstract][Full Text] [Related]
15. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905 [TBL] [Abstract][Full Text] [Related]
16. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [TBL] [Abstract][Full Text] [Related]
17. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679 [TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension. Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119 [TBL] [Abstract][Full Text] [Related]
19. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination. Papademetriou V; Hainer JW; Sugg J; Munzer D; Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766 [TBL] [Abstract][Full Text] [Related]
20. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]